Latest filing published 10 Jul 2026 for Edwards Lifesciences Corp. Read the official filing
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Theodora Mistras discloses dealings in 2 companies, chiefly Viatris Inc and Edwards Lifesciences Corp. The record holds 7 filings, for trades running from 1 January 2025 to 9 July 2026.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
The latest filing, published on 10 July 2026, reports a share grant in Edwards Lifesciences Corp. The median gap between a trade and its publication by SEC (Form 4) is 1 day. US insiders must file a Form 4 within two business days of a trade. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
7 of 7 declarations